Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Triple Negative Breast Cancer (TNBC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04755868
What this trial is testing

Talazoparib Maintenance Therapy in Triple-negative Breast Cancer

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Yonsei University 206
Testing effectiveness (Phase 2)Looking for participantsNCT06401005
What this trial is testing

SBRT, Chemotherapy, and AK104 Neoadjuvant Therapy for Triple-negative Breast Cancer (TNBC)

Who this might be right for
Breast Cancer
Hubei Cancer Hospital 51
Testing effectiveness (Phase 2)Study completedNCT02435680
What this trial is testing

Efficacy Study of MCS110 Given With Carboplatin and Gemcitabine in Advanced Triple Negative Breast Cancer (TNBC)

Who this might be right for
Advanced Triple Negative Breast Cancer (TNBC) With High TAMs
Novartis Pharmaceuticals 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07419880
What this trial is testing

Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast Cancer

Who this might be right for
Triple -Negative Breast Cancer
Fudan University 46
Not applicableLooking for participantsNCT07067138
What this trial is testing

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

Who this might be right for
Breast CancerBreast CarcinomaCancer of the Breast+1 more
National Cancer Institute (NCI) 175
Testing effectiveness (Phase 2)WithdrawnNCT03872505
What this trial is testing

Pre-operAtive Non-Anthracycline Chemotherapy, Durvalumab +/- RAdiation Therapy in Triple Negative Breast Cancer

Who this might be right for
Breast CancerTriple Negative Breast Cancer
Cedars-Sinai Medical Center
Large-scale testing (Phase 3)Not Yet RecruitingNCT07760844
What this trial is testing

An Open-Label, Randomized Phase III Study of Trastuzumab Rezetecan With or Without Everolimus in First to Third Line LAR Subtype TNBC

Who this might be right for
Breast CancerTriple Negative Breast Cancer (TNBC)
Fudan University 180
Large-scale testing (Phase 3)Study completedNCT03125902
What this trial is testing

Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC)

Who this might be right for
Triple-Negative Breast Cancer
Hoffmann-La Roche 653
Not applicableNot Yet RecruitingNCT07551765
What this trial is testing

Diet-drive Gut Microbiome and Outcome in Patients With Early-stage Triple-negative Breast Cancer Undergoing Neoadjuvant Chemotherapy and Immunotherapy.

Who this might be right for
Triple Negative Breast Cancer (TNBC), Early Setting
Barts & The London NHS Trust 300
Not applicableLooking for participantsNCT07622836
What this trial is testing

A Prospective, Multicenter, Phase II Clinical Study of Postoperative Chemotherapy Combined With QL1706 for High-risk Triple-negative Breast Cancer.

Who this might be right for
TNBCAdjuvant TherapyLymph Node Positive
The First Affiliated Hospital with Nanjing Medical University 59
Early research (Phase 1)Study completedNCT03454451
What this trial is testing

CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers

Who this might be right for
Non-Small Cell Lung CancerRenal Cell CancerColorectal Cancer+10 more
Corvus Pharmaceuticals, Inc. 117
Testing effectiveness (Phase 2)Study completedNCT03106077
What this trial is testing

Mirvetuximab Soravtansine as First Line in Treating Patients With Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8+18 more
M.D. Anderson Cancer Center 96
Early research (Phase 1)Not Yet RecruitingNCT07272642
What this trial is testing

A Phase 1, Multicenter Imaging Study of LNTH-2403 in Participants With Locally Advanced or Metastatic Solid Tumors.

Who this might be right for
ImagingColorectal CancerHead and Neck Squamous Cell Carcinoma+2 more
Radiopharm Theranostics, Ltd 16
Testing effectiveness (Phase 2)Looking for participantsNCT07342283
What this trial is testing

QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Triple-Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer (TNBC)
Affiliated Hospital of Nantong University 30
Not applicableUnknownNCT03332368
What this trial is testing

Clinical Study on Triple Negative Breast Cancer With Chinese Medicine

Who this might be right for
Progression-Free-SurvivalRecurrenceOverall Survival
Sheng Liu 620
Early research (Phase 1)Looking for participantsNCT07020117
What this trial is testing

[225Ac]Ac-AKY-1189 in Patients With Solid Tumors

Who this might be right for
Urothelial Carcinoma BladderTriple Negative Breast Cancer (TNBC)Hormone Receptor Positive Breast Adenocarcinoma+4 more
Aktis Oncology, Inc. 150
Large-scale testing (Phase 3)Looking for participantsNCT06732323
What this trial is testing

A Phase III Study of ESG401 for Unresectable Recurrent or Metastatic Triple-Negative Breast Cancer

Who this might be right for
Triple-Negative Breast Cancer (TNBC)
Qilu Pharmaceutical Co., Ltd. 504
Testing effectiveness (Phase 2)Study completedNCT03504488
What this trial is testing

CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2)

Who this might be right for
Non Small Cell Lung CancerTriple Negative Breast CancerMelanoma+1 more
BioAtla, Inc. 132
Testing effectiveness (Phase 2)Looking for participantsNCT06649331
What this trial is testing

Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer

Who this might be right for
Advanced Breast CancerMetastatic Breast CancerTriple Negative Breast Cancer (TNBC)+2 more
Fudan University 160
Testing effectiveness (Phase 2)UnknownNCT06598046
What this trial is testing

A Single-arm, Prospective Phase Ⅱ Clinical Study of Utidelone Combined with Capecitabine in the Treatment of Active Brain Metastasis of TNBC

Who this might be right for
Metastatic Breast Cancer
Henan Cancer Hospital 48
Next Page